Free tool
FAERS Monitor: Hadlima
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761059 or its brand name (Hadlima, Adalimumab-Bwwd). Reports on generic versions are filed under their own applications.
Reports
10
Serious
4
40% of reports
Hospitalization
2
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity2
- injection site pain2
- tachypnoea2
- drug ineffective1
- general physical health deterioration1
- headache1
- influenza like illness1
- pain1
- rash pruritic1
- rash pustular1
- tachycardia1
- therapy interrupted1
- uveitis1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,149 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| tachypnoea | 2 | 309.6 | 89.6 | 345 |
| rash pustular | 1 | 288.8 | 45.0 | 71 |
| uveitis | 1 | 155.1 | 24.2 | 38 |
| rash pruritic | 1 | 38.8 | 6.0 | 9 |
| therapy interrupted | 1 | 29.4 | 4.6 | 6 |
| influenza like illness | 1 | 25.6 | 4.0 | 5 |
| tachycardia | 1 | 23.7 | 3.7 | 5 |
| drug hypersensitivity | 2 | 21.7 | 6.3 | 22 |
| general physical health deterioration | 1 | 18.2 | 2.8 | 4 |
| injection site pain | 2 | 13.7 | 4.0 | 13 |
| pain | 1 | 3.4 | 0.5 | 0 |
| headache | 1 | 3.4 | 0.5 | 0 |
| drug ineffective | 1 | 1.6 | 0.2 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.